Quantum arrives on two fronts at once: a platform deal and a security deadline
Intel is acquiring Classiq to build a full-stack quantum platform, while Oracle Database 19c adds post-quantum cryptography. Opportunity and deadline arrived together.
21 stories, 73 Manifests cited.
Intel is acquiring Classiq to build a full-stack quantum platform, while Oracle Database 19c adds post-quantum cryptography. Opportunity and deadline arrived together.
CoreWeave is adding capacity and a global network, Vultr argues for decentralized inference, and Hive has rebranded as an enterprise inference platform.
Parloa is selling through SAP and Sierra through Google Cloud Marketplace, while HeyGen shows what happens when a company builds its own voice model from its own traffic.
Tandem, Commure, and a Dubai hospital partnership all point at the same bottleneck: the administrative work around care.
A math podcast, a chemistry sandbox with pre-measured data, and a new framework all ask the same question: how do we know the machine got it right?
Oracle, Databricks and Writer show the same pitch: keep the system you run, and add governed AI intelligence on top of it.
Four preprints show the same failure: models answer fluently while ignoring the image, the instruction change or the evidence they were asked to use.
Genspark, Luma and Runway are packaging full production workflows, while model choice inside those workflows still changes cost and capability.
IBM, Oracle and Snowflake are each adding the same missing layer: a record of who an agent is, what it may touch, and how to stop it.
A sharper Arctic sea ice forecast, population-specific beech adaptation and a drought gene in alfalfa all reward looking closer, not averaging wider.
Advent closed a $30 billion fund complex with $13 billion of realizations behind it, while smaller checks backed a photonic quantum builder and a clinic software firm scaling across Europe.
PIMCO, Wellington and Callan describe the same reset from three sides: income is back, weak borrowers pay more, and the vehicles that lagged for years are slowly repairing.
Two research houses expect a pause paired with a hawkish message, markets price only a small chance of a move this week, and the dollar is already trading the hawkish version.
Brazil repriced on a surprise reelection while Mexico's factories kept recovering on United States demand for AI inputs. Robeco's case for picking countries fits both.
The S-1 behind a planned Nasdaq listing pairs fast revenue growth with huge non-cash charges and long compute obligations. The operating line, not the net line, is where the story sits.
A retailer wants a bold UK budget, a PIMCO adviser expects a small one with a bigger reckoning in the spring, and a Bloomberg columnist explains why France's 170-basis-point spread is the cautionary tale.
Four preprints point the same way: aim delivery, vaccination and surveillance at the specific pathogen and its behaviour, instead of widening antibiotic exposure.
Fibrinolysis resistance tracks with organ failure and death in intensive care, while maternal colonisation predicts newborn sepsis in Tanzania.
Across gut, eye, chest and general medical imaging, new preprints show models failing on new sites, new artefacts and new tasks.
A 64-55 Game 5 win built on defense and Kiah Stokes' all-around night gives Golden State a 3-2 Finals lead. Atlanta must win Thursday morning in its own building or its season ends.
Basin groundwater, erosive landslides and a Nepal cascade all show why single-trigger hazard maps miss the real risk.